Provider
QP37-18 Pharmacy Benefit Update - Brand Copaxone 20mg/mL and 40 mg/ML Non-Formulary
Program effective Date: May 21, 2018
Search Results
Displaying 3041 - 3050 of 4138 results
Provider
QP13-16 Provider Cost Data Update
Program effective Date: Jun 01, 2016
Provider
P56-16 A New Drug, Dupilumab Will Require Prior Authorization
Program effective Date: Nov 22, 2016
Provider
P34-16 New Drug-Related Prior Authorization Criteria for Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blocker Prior Authorization with Quantity Limit Program
Program effective Date: Jul 27, 2016
Provider
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 30, 2017
Provider
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Program effective Date: Oct 10, 2016
Provider
P56-17 Implementation of a Medical Drug Exclusions List
Program effective Date: Oct 16, 2017
Provider
P5R1-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Jul 05, 2017
Provider
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Program effective Date: Oct 28, 2016
Provider
P53-16 New Notification Requirement for Outpatient Dialysis Services for Commercial Products and Subscribers in Government Programs
Program effective Date: Nov 09, 2016